ROVI — Laboratorios Farmaceuticos Rovi Share News
0.000.00%
Last trade - 00:00- €2.95bn
- €2.94bn
- €743.48m
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Rovi receives non-binding offers for manufacturing business (updated)
Brief: Rovi Confirms Non-Binding Offers For Third-Party Manufacturing Unit
Deals of the day-Mergers and acquisitions
Antin, Cinven, CVC, KKR and Permira bid to buy unit of Spain's Rovi, Expansion reports
Brief: Rovi Sees 200-300 Mln Euros Potential Risperidone Sales Globally In Upcoming Years
BNP Cuts Rovi To 'Neutral' Amid Absence Of Immediate Growth Drivers
Spanish stocks - Factors to watch on June 12
Brief: Rovi Ends Buy-Back Programme Of About 4.3% Share Capital
Spanish stocks - Factors to watch on May 21
Brief: Rovi To Propose Capital Reduction Up To 3.3 Mln Treasury Shares
Spanish stocks - Factors to watch on May 15
Spanish stocks - Factors to watch on May 8
Brief: Rovi Expects Its Operating Revenue To Decrease By Mid-Single-Digit Percentage Vs 2023
Brief: ROVI Q1 Revenue EUR 151.2 Million
Spanish stocks - Factors to watch on May 6
Brief: Rovi Signs Agreement To Manufacture Pre-Filled Syringes For Global Pharmaceutical Company
Brief: Rovi Awards Atos Outsourcing Of Its IT Systems And Workplace Management